Company profile: Rakuten Medical
1.1 - Company Overview
Company description
- Provider of investigational cancer therapies based on the proprietary Alluminox photoimmunotherapy platform, which combines a drug with targeting moieties and a light-activating device using non-thermal illumination to selectively target cancer cells; includes ASP-1929, an Alluminox-developed drug with dye-conjugated targeting moieties, approved in Japan for treating certain cancers.
Products and services
- ASP-1929: An investigational-stage drug engineered on Alluminox, featuring a targeting moiety conjugated with dyes for selective cell binding, and approved in Japan for certain cancers
- Alluminox Platform: A proprietary, photoimmunotherapy treatment system integrating a drug with targeting moieties and a non-thermal light device to activate it for selective cancer cell targeting
- Investigational Cancer Therapies: Photoimmunotherapy-based therapies architected on Alluminox that couple targeting moieties with a non-thermal light activation device to selectively engage cancer cells during treatment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rakuten Medical
KisoJi Biotechnology
HQ: Canada
Website
- Description: Provider of biotechnology solutions for healthcare and life sciences R&D, offering KisoMouse, a transgenic mouse platform for single-domain antibodies; KisoSeek, an NGS- and AI-guided structural antibody screening tool; KisoBody, a multi-functional, multi-specific antibody format; and therapeutic candidates including KJ-103 (TROP2, IND-enabling, solid tumors), KJ-101 (PD1/CD47/D2, IND-enabling), and KJ-102 (PD1/CD47/CD36, research, AML).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KisoJi Biotechnology company profile →
CarThera
HQ: France
Website
- Description: Provider of therapeutic ultrasound-based medical devices for treating brain disorders, including SonoCloud, an intracranial implant that uses low-intensity pulsed ultrasound to temporarily open the blood-brain barrier for enhanced delivery of therapeutic agents, and SonoCloud-9, a nine-emitter version to open larger regions; also conducts preclinical and clinical R&D combining SonoCloud with therapeutic agents to treat brain tumors and neurodegenerative diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CarThera company profile →
RedPath Integrated Pathology
HQ: United States
Website
- Description: Provider of reference laboratory services and oncology case support, offering PathFinderTG, a testing platform for resolving diagnoses from the original pathology specimen, serving pathologists, clinicians, and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RedPath Integrated Pathology company profile →
Checkpoint Therapeutics
HQ: United States
Website
- Description: Provider of immuno-oncology and targeted oncology therapies in development, advancing a pipeline including cosibelimab (fully human anti-PD-L1 monoclonal antibody), olafertinib (oral third-generation irreversible EGFR inhibitor for NSCLC), CK-103 (BET bromodomain inhibitor), CK-302 (agonistic GITR antibody), and an anti-CAIX antibody for renal cell carcinoma, plus product purchases, in-licensing and co-development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Checkpoint Therapeutics company profile →
Day One Bio
HQ: United States
Website
- Description: Provider of targeted therapies for life-threatening diseases, including OJEMDA (tovorafenib), FDA-approved for children with BRAF-altered relapsed or progressive pediatric low-grade glioma; advancing investigational MAPK-pathway inhibitors tovorafenib and pimasertib and conducting FIREFLY-1/2 and FIRELIGHT-1 trials in brain and solid tumors with MAPK pathway aberrations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Day One Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rakuten Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rakuten Medical
2.2 - Growth funds investing in similar companies to Rakuten Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rakuten Medical
4.2 - Public trading comparable groups for Rakuten Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →